Gene · 4440
Papers1,911
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 1,911
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Global Transcriptional Analyses of the Wnt-Induced Development of Neural Stem Cells from Human Pluripotent Stem Cells. | Int J Mol Sci | 2021 | 34299091 | PubTator, text mining | PubMed |
| The Next-Generation of Combination Cancer Immunotherapy: Epigenetic Immunomodulators Transmogrify Immune Training to Enhance Immunotherapy. | Cancers (Basel) | 2021 | 34298809 | PubTator, text mining | PubMed |
| HDAC Inhibitors: Dissecting Mechanisms of Action to Counter Tumor Heterogeneity. | Cancers (Basel) | 2021 | 34298787 | PubTator, text mining | PubMed |
| Oncogenic Functions and Clinical Significance of Circular RNAs in Colorectal Cancer. | Cancers (Basel) | 2021 | 34298612 | PubTator, text mining | PubMed |
| Knockdown of the prognostic cancer stem cell marker Musashi-1 decreases radio-resistance while enhancing apoptosis in hormone receptor-positive breast cancer cells via p21WAF1/CIP1. | J Cancer Res Clin Oncol | 2021 | 34291358 | PubTator, text mining | PubMed |
| The pyriproxyfen metabolite, 4'-OH-PPF, disrupts thyroid hormone signaling in neural stem cells, modifying neurodevelopmental genes affected by ZIKA virus infection. | Environ Pollut | 2021 | 34289950 | PubTator, text mining | PubMed |
| ROBO1 Promotes Homing, Dissemination, and Survival of Multiple Myeloma within the Bone Marrow Microenvironment. | Blood Cancer Discov | 2021 | 34268498 | PubTator, text mining | PubMed |
| A comprehensive review of the functions of YB-1 in cancer stemness, metastasis and drug resistance. | Cell Signal | 2021 | 34224843 | PubTator, text mining | PubMed |
| Systematic Review of the Neural Effect of Electroconvulsive Therapy in Patients with Schizophrenia: Hippocampus and Insula as the Key Regions of Modulation. | Psychiatry Investig | 2021 | 34218638 | PubTator, text mining | PubMed |
| Metabolic Remodeling in Glioma Immune Microenvironment: Intercellular Interactions Distinct From Peripheral Tumors. | Front Cell Dev Biol | 2021 | 34211978 | PubTator, text mining | PubMed |
| Causes of Phenotypic Variability and Disabilities after Prenatal Viral Infections. | Trop Med Infect Dis | 2021 | 34205913 | PubTator, text mining | PubMed |
| Menstrual Blood-Derived Endometrial Stem Cells' Impact for the Treatment Perspective of Female Infertility. | Int J Mol Sci | 2021 | 34202508 | PubTator, text mining | PubMed |
| The Role of Notch3 Signaling in Cancer Stemness and Chemoresistance: Molecular Mechanisms and Targeting Strategies. | Front Mol Biosci | 2021 | 34195229 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Prognostic Value of MEX3A and Its Relationship with Immune Infiltrates in Ovarian Cancer. | J Immunol Res | 2021 | 34189143 | PubTator, text mining | PubMed |
| The Function and Prognostic Value of RNA-Binding Proteins in Colorectal Adenocarcinoma Were Analyzed Based on Bioinformatics of Smart Medical Big Data. | J Healthc Eng | 2021 | 34188789 | PubTator, text mining | PubMed |
| Differential expression of stem cell markers in proliferating cells in glioma. | J Cancer Res Clin Oncol | 2021 | 34170383 | PubTator, text mining | PubMed |
| Msi1 promotes breast cancer metastasis by regulating invadopodia-mediated extracellular matrix degradation via the Timp3-Mmp9 pathway. | Oncogene | 2021 | 34155343 | PubTator, text mining | PubMed |
| Spidroin Silk Fibers with Bioactive Motifs of Extracellular Proteins for Neural Tissue Engineering. | ACS Omega | 2021 | 34151105 | PubTator, text mining | PubMed |
| MUSASHI-2 confers resistance to third-generation EGFR-tyrosine kinase inhibitor osimertinib in lung adenocarcinoma. | Cancer Sci | 2021 | 34145929 | PubTator, text mining | PubMed |
| Spatial and cell type transcriptional landscape of human cerebellar development. | Nat Neurosci | 2021 | 34140698 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4440/papers?page=26